This is a randomized, single blind, parallel-arm, multi-center, non-inferior clinical trial. 174 patients are recruited in total, and they are treated by Guided Tissue Regeneration (GTR). The patients are split in to two groups evenly: 87 in the experimental group and 87 in the control group.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The change of CAL at 12 weeks after surgery
Timeframe: 12 weeks
The change of CAL at 24 weeks after surgery
Timeframe: 24 weeks
The change of PD at 12 weeks after surgery
Timeframe: 12 weeks
The change of PD at 24 weeks after surgery
Timeframe: 24 weeks